Navigation Links
Operational research seeks benefit for stroke victims
Date:2/15/2012

Researchers from the University of Exeter, Peninsula College of Medicine and Dentistry (PCMD), are working with clinicians from the South Western Ambulance Service NHS Foundation Trust (SWASFT) and the Royal Devon & Exeter Hospital NHS Foundation Trust (RD&E) to reduce the time it takes from the start of a stroke to the administration of vital clot-busting drug treatment.

The researchers are from the PCMD-based National Institute for Health Research (NIHR) Peninsula Collaboration for Health, Operational Research and Development (PenCHORD), which is part of the NIHR Peninsula Collaboration for Leadership and Applied Health Research and Care (PenCLAHRC).

The study is investigating the whole process of emergency treatment that follows when a person suffers an acute stroke from a blocked artery in the brain. For most patients in this situation, the earliest possible administration of the clot-busting drug Alteplase can greatly improve their chances of recovery called thrombolysis. The drug is currently licensed for delivery up to three hours from the onset of a stroke, but in that time the patient needs to call an ambulance, get to hospital, have a brain scan, and be assessed by specialists before receiving the treatment.

The research team is working with healthcare professionals from SWASFT and the RD&E to analyse the various steps by which a stroke patient is identified, transported to hospital and treated. This includes paramedics, the emergency department (ED) team, triage nurses, the acute stroke team and the radiology department (which performs the brain scans).

By investigating what happens 'on the ground', researchers have been able to create computer simulations that imitate the various permutations of stroke victim identification, transport, arrival at hospital and treatment.

The computer model takes into account the number and level of healthcare professionals involved with each case, the time of day or night, and the 'busy-ness' of the various hospital departments involved in the treatment process.

Their analysis of over 1400 episodes of care has enabled them to identify the bottlenecks in the system, and take steps to speed up the process of emergency care which can lead to earlier clot-busting treatment. The researchers estimate that the number of people whose stroke could be greatly improved by earlier treatment could treble.

The research has already led to the introduction of a pilot for early referral to the acute stroke team at the moment the ambulance arrives at the ED. The pilot was introduced in December 2011 and early figures already show that the changes have led to a doubling of the number of patients admitted with acute stroke receiving clot-busting treatment within the three hour window (the national average is just five per cent: the national target is 10 per cent).

The research team is currently working on a thorough evaluation of the pilot scheme, as well as developing a mobile phone referral method that ambulance crews can use to inform the stroke team that a patient is on their way so reducing the time the patient spends in the ED before receiving thrombolysis.

Professor Stuart Logan, Director of PenCLAHRC, commented: "This project shows just how powerful close collaboration between academics, clinicians and managers can improve patient outcome. Research can sometimes feel like a luxury, this is the kind of work that reminds us of why with proper partnerships can have immediate impact. We look forward to the next stages of the study, which has the potential for major impact nationally and internationally."

Dr Martin James, Consultant Physician and Lead Clinician for Stroke at the RD&E said: "Our work with academic researchers in PenCHORD to build the computer simulation has been a great example of the NHS collaborating with Universities to improve care. Using the simulation has enabled us to identify and unblock the bottlenecks in getting the treatment to patients much more quickly than we could in the past. What used to takes us months or even years of trial and error can be accomplished in an afternoon using the simulation. This means that research findings can be applied to the care of patients much more quickly, and reduce the misery of disability after a stroke, which is what these collaborations are all about."

James Wenman, the Clinical Development Manager for the South Western Ambulance Service NHS Foundation Trust said, "We are delighted to be working in partnership with the Peninsula College of Medicine and Dentistry, and our colleagues at the RD&E on this important project. Improving the services we provide to patients who have experienced a stroke is a key priority for SWASFT. The sooner patients receive treatment, the greater their chance of survival, which means they are more likely to make a full recovery. The Trust aims to deliver the right care in the right place at the right time, and this initiative will undoubtedly help us to achieve this in our ongoing quest to save lives."


'/>"/>
Contact: Andrew Gould
andrew.gould@pcmd.ac.uk
139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Related medicine news :

1. CellTrak Technologies Inc. Wins Prestigious I Award for Operational Effectiveness
2. MEDNET and Hielix Awarded the State of North Dakota Contract for Statewide Health Information Exchange (HIE) Strategic and Operational Plans
3. Lumension Unveils Intelligent Application Whitelisting that Operationalizes a Proactive Endpoint Security Approach
4. GW researchers reveal digital transcriptome of breast cancer
5. PRP treatment aids healing of elbow injuries say researchers
6. Helmet fit critical to preventing concussion, say researchers
7. Pot Use Could Double Risk of Car Crash, Research Shows
8. Rothman at Jefferson researchers show benefits of local anesthesia after knee replacement surgery
9. Researchers find important target playing role in tobacco-related lung cancers
10. Heavy lifting for cancer research
11. Boston University research suggests new pathways for cancer progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... MadgeTech will be showcasing its line ... in Warner, New Hampshire at the MadgeTech headquarters. With products sold in more than ... by government agencies, including NASA. , In 2012, NASA strategically set up 17 ...
(Date:5/26/2016)... ... May 26, 2016 , ... Memorial Day Weekend marks ... Amica Insurance is sharing tips to make sure your family and vehicle are ... National Safety Council, there may be 439 deaths and an additional 50,500 serious injuries ...
(Date:5/26/2016)... ... May 26, 2016 , ... Nike Yoga Camps at ... daily practices, arts & crafts, discussions, and games all geared towards enhancing your ... have combined backgrounds in kids’ yoga, collegiate sport yoga instruction, and global yoga ...
(Date:5/26/2016)... ... May 26, 2016 , ... Bunion Bootie , the manufacturer ... treatment was more than humbled by customer demand over the Mother’s Day Weekend promotion. ... sale. Now that Bunion Bootie has completely replenished its inventory levels, it hopes to ...
(Date:5/26/2016)... ... May 26, 2016 , ... Workrite ... sales leadership and to further develop their rapidly expanding portfolio of customer and ... with a concentration in Marketing and an M.B.A. with concentration in management from ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 2016 A key trend that ... emergence of new treatments. Cardax, a development stage life ... The therapy is expected to fulfil large unmet medical ... conducting studies to develop new treatments for osteoarthritis. One ... involved in osteoarthritis are being investigated, and early trials ...
(Date:5/26/2016)... Since its commercial introduction in ... life science tool for conducting genetic studies in a ... in its new report that the industry sits on ... by a range of new applications in the clinical ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Since the Human ...
(Date:5/25/2016)... HILDEN , Deutschland und GERMANTOWN, ... Zusammenarbeit mit Therawis bedient ... Entscheidungen bei Brustkrebs   QIAGEN N.V. ... QIA) gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung ... prädiktiver Assays für die Onkologie eingegangen zu sein. ...
Breaking Medicine Technology: